Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effects of Cranberry Juice on Cardiovascular Risk Factors

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Nuoroda įrašoma į mainų sritį
StatusasBaigta
Rėmėjai
Penn State University
Bendradarbiai
Ocean Spray Cranberries, Inc.

Raktažodžiai

Santrauka

The purpose of this study is to evaluate the effects of cranberry juice on central and peripheral blood pressure, indices of arterial stiffness, lipid and lipoprotein concentrations and size characteristics, and HDL function. The investigators hypothesize that the bioactive compounds in cranberry juice may elicit beneficial effects on blood pressure and arterial health, as well as LDL-C and HDL function.

apibūdinimas

The investigators propose to conduct a 2-period randomized, crossover, placebo-controlled study to evaluate the effect of cranberry juice on central and peripheral blood pressure, indices of arterial stiffness, lipid and lipoprotein concentrations and size characteristics, and HDL function. Eligibility requires non-smoking men and women to be 30 to 65 years of age with BMI greater than or equal to 18 and less than or equal to 39, total cholesterol below 273 mg/dL for men and below 284 mg/dL for women, triglycerides below 350 mg/dL, and have systolic blood pressure of 120 to 159 mmHg and/or diastolic blood pressure of 80 to 99 mmHg. Subjects will undergo randomized treatments including 500 mL/d cranberry juice beverage and 500 mL/d of a color and taste matched placebo beverage. The two 8 to 12 week treatment periods will be separated by an 8 week washout.

Datos

Paskutinį kartą patikrinta: 11/30/2019
Pirmasis pateikimas: 09/17/2015
Numatytas registravimas pateiktas: 09/20/2015
Pirmas paskelbtas: 09/21/2015
Paskutinis atnaujinimas pateiktas: 12/11/2019
Paskutinis atnaujinimas paskelbtas: 12/12/2019
Faktinė studijų pradžios data: 09/30/2015
Numatoma pirminio užbaigimo data: 04/30/2019
Numatoma studijų užbaigimo data: 04/30/2019

Būklė ar liga

Cardiovascular Disease Risk Factors

Intervencija / gydymas

Dietary Supplement: Cranberry Juice Beverage

Dietary Supplement: Placebo Beverage

Fazė

-

Rankų grupės

RankaIntervencija / gydymas
Experimental: Cranberry Juice Beverage
16 ounces of 54% cranberry juice cocktail
Dietary Supplement: Cranberry Juice Beverage
16 ounces of 54% cranberry juice cocktail
Placebo Comparator: Placebo Beverage
Color, calorie, and taste matched beverage without cranberry bioactives
Dietary Supplement: Placebo Beverage
Color, calorie, and taste matched beverage without cranberry bioactives

Tinkamumo kriterijai

Amžius, tinkami studijuoti 30 Years Į 30 Years
Tinkamos studijoms lytysAll
Priima sveikus savanoriusTaip
Kriterijai

Inclusion Criteria:

1. Men and women 30-65 years of age

2. BMI ≥ 18 and ≤ 39 kg/m^2

3. Total cholesterol below 273 mg/dL for men and below 284 mg/dL for women

4. Triglycerides below 350 mg/dL

5. Non-smokers

6. At least one of the following:

1. Systolic blood pressure 120-159 mmHg

2. Diastolic blood pressure 80-99 mmHg

Exclusion Criteria:

1. History of acute or chronic inflammatory conditions or heart disease, kidney disease, liver disease, autoimmune disorders, or thyroid disease (unless controlled by medication and blood results within previous 6 months are provided)

2. History of diabetes mellitus (and/or a fasting glucose >126 mg/dL at screening)

3. Stage II hypertension (blood pressure ≥ 160/100 mmHg)

4. Lactation, pregnancy, or desire to become pregnant during the study

5. Unwillingness to discontinue nutritional supplements, herbs, or vitamins unless approved by investigator

6. Use of medications/supplements for elevated lipids, blood pressure, or glucose

7. Chronic use of non-steroidal anti-inflammatory or immunosuppressant medication

8. Conditions requiring the use of steroids

9. Unwillingness to refrain from blood donation prior to and during the study

10. Any medical condition or abnormal laboratory value that is judged clinically significant by an investigator

11. Allergy or sensitivity to cranberry juice or any ingredient in the study beverages

Rezultatas

Pirminės rezultatų priemonės

1. Central Blood Pressure [Change from baseline after 8 week treatments with cranberry and placebo]

Aortic (central) blood pressure measured using the SphygmoCor system

2. Peripheral Blood Pressure [Change from baseline after 8 week treatments with cranberry and placebo]

Peripheral blood pressure measured using the SphygmoCor system

Antrinės rezultatų priemonės

1. Efflux capacity of HDL [Change from baseline after 8 week treatments with cranberry and placebo]

Ability to carry out reverse cholesterol transport measured using in vitro assay

2. Augmentation Index [Change from baseline after 8 week treatments with cranberry and placebo]

Augmentation index measured using the SphygmoCor system

3. Pulse Wave Velocity [Change from baseline after 8 week treatments with cranberry and placebo]

Pulse wave velocity measured using the SphygmoCor system

4. LDL-C [Change from baseline after 8 week treatments with cranberry and placebo]

LDL-C values calculated using the Friedewald equation

5. LDL Particle Size [Change from baseline after 8 week treatments with cranberry and placebo]

LDL particle size measured using a Vertical Auto Profile (VAP) Test

6. Total Cholesterol [Change from baseline after 8 week treatments with cranberry and placebo]

Total cholesterol values determined by enzymatic procedures

7. Triglycerides [Change from baseline after 8 week treatments with cranberry and placebo]

Triglyceride values determined using enzymatic procedures

8. HDL-C [Change from baseline after 8 week treatments with cranberry and placebo]

HDL-C will be estimated according to the modified heparin-manganese procedure

9. Oxidized LDL (oxLDL) [Change from baseline after 8 week treatments with cranberry and placebo]

Plasma concentrations of oxLDL will be measured using ELISA kits

10. Malondialdehyde (MDA) [Change from baseline after 8 week treatments with cranberry and placebo]

MDA will be measured using the thiobarbituric acid reactive substances (TBARS) assay

11. High Sensitivity C Reactive Protein (hs-CRP) [Change from baseline after 8 week treatments with cranberry and placebo]

hs-CRP will be measured by latex-enhanced immunonephelometry

12. 24-hr Ambulatory Blood Pressure [Change from baseline after 8 week treatments with cranberry and placebo]

Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge